Nintedanib(BIBF1120) in Thyroid Cancer

Clinical trial NCT01788982 · COMPLETED

Trial details

NCT number: NCT01788982
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Medullary Thyroid Cancer (MTC)Differentiated Thyroid Cancer (DTC)

Start date: 2014-05-01
Primary completion: 2019-08-28
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.